Grey Wolf Health Corp. (TSXV:WOLF)
Canada · Delayed Price · Currency is CAD 1.750
+0.020 (1.16%)
Sep 30, 2026, 3:54 PM EST
Grey Wolf Health Revenue
Grey Wolf Health had revenue of 10.58M CAD in the quarter ending June 30, 2026, with 11.06% growth. This brings the company's revenue in the last twelve months to 37.65M, up 21.33% year-over-year. In the year 2025, Grey Wolf Health had annual revenue of 35.76M with 33.30% growth.
Revenue (ttm)
37.65M
Revenue Growth
+21.33%
P/S Ratio
1.61
Revenue / Employee
n/a
Employees
40
Market Cap
60.62M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 35.76M | 8.94M | 33.30% |
| Dec 31, 2024 | 26.83M | 1.42M | 5.58% |
| Dec 31, 2023 | 25.41M | 2.78M | 12.26% |
| Dec 31, 2022 | 22.64M | 9.54M | 72.85% |
| Dec 31, 2021 | 13.10M | 5.41M | 70.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Apotex Health | 3.20B |
| Extendicare | 1.98B |
| Curaleaf Holdings | 1.87B |
| Green Thumb Industries | 1.72B |
| Planet 13 Holdings | 131.28M |
| Vext Science | 71.97M |
| Neurothera Labs | 965.67K |
| DIAGNOS | 65.48K |